Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 450 of 2400 entries
View as:

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

Phase: N/A Priority: Normal
NCT ID: NCT00001020 Org: User:
Start: - End: 02/28/95 Due: 02/28/96

Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT02207920 Org: User:
Start: 07/31/14 End: 12/31/15 Due: 12/31/16

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

Phase: N/A Priority: Normal
NCT ID: NCT02921997 Org: User:
Start: 11/07/16 End: 02/14/18 Due: 02/14/19

A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection

Phase: N/A Priority: Normal
NCT ID: NCT00005572 Org: User:
Start: - End: - Due: -

A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

Phase: N/A Priority: Normal
NCT ID: NCT00001009 Org: User:
Start: - End: 04/30/90 Due: 04/30/91

Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT01674205 Org: User:
Start: 09/30/12 End: 06/30/13 Due: 06/30/14

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00001644 Org: User:
Start: 03/03/97 End: 02/17/10 Due: 02/17/11

Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)

Phase: N/A Priority: Normal
NCT ID: NCT00028236 Org: User:
Start: 12/10/01 End: 07/25/11 Due: 07/25/12

Training Protocol on the Natural History of Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT01212003 Org: User:
Start: 06/30/11 End: - Due: -

Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults

Phase: N/A Priority: Normal
NCT ID: NCT00133471 Org: User:
Start: 03/31/05 End: 12/31/05 Due: 12/31/06

Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring

Phase: N/A Priority: Normal
NCT ID: NCT00434070 Org: User:
Start: 02/07/07 End: 02/07/13 Due: 02/07/14

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05078905 Org: User:
Start: 10/13/21 End: 01/01/50 Due: 01/01/51

Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study

Phase: N/A Priority: Normal
NCT ID: NCT00346398 Org: User:
Start: 05/31/06 End: 07/31/11 Due: 07/31/12

Network on Antimicrobial Resistance in Staphylococcus Aureus

Phase: N/A Priority: Normal
NCT ID: NCT00341913 Org: User:
Start: 03/16/00 End: 06/17/08 Due: 06/17/09

Pilot Study Freeze and Transport Immune Cells

Phase: N/A Priority: Normal
NCT ID: NCT00138268 Org: User:
Start: - End: 02/28/05 Due: 02/28/06

Acute HIV Infection Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT00296660 Org: User:
Start: 06/30/06 End: 06/30/13 Due: 06/30/14

Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)

Phase: N/A Priority: Normal
NCT ID: NCT02344407 Org: User:
Start: 01/20/15 End: 11/01/20 Due: 11/01/21

SARS Survivor Evaluations

Phase: N/A Priority: Normal
NCT ID: NCT00523276 Org: User:
Start: - End: 06/30/11 Due: 06/30/12

Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT00145249 Org: User:
Start: 05/31/05 End: 04/30/08 Due: 04/30/09

Study of Factors Involved in Resistance to Severe Malaria

Phase: N/A Priority: Normal
NCT ID: NCT00368810 Org: User:
Start: 02/21/06 End: 11/30/06 Due: 11/30/07

Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly

Phase: N/A Priority: Normal
NCT ID: NCT00347555 Org: User:
Start: 05/31/06 End: 04/30/08 Due: 04/30/09

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

Phase: N/A Priority: Normal
NCT ID: NCT00100633 Org: User:
Start: 12/31/04 End: 10/31/07 Due: 10/31/08

Malaria Transmission and Immunity in Highland Kenya

Phase: N/A Priority: Normal
NCT ID: NCT00393757 Org: User:
Start: 10/31/06 End: 01/31/11 Due: 01/31/12

Donor Stem Cell Transplantation for Congenital Immunodeficiencies

Phase: N/A Priority: Normal
NCT ID: NCT00426517 Org: User:
Start: 01/19/07 End: 11/01/19 Due: 11/01/20

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Phase: N/A Priority: Normal
NCT ID: NCT00046033 Org: User:
Start: - End: - Due: -